Systemic ATP infusion improves spontaneous pain and tactile allodynia, but not tactile hypesthesia, in patients with postherpetic neuralgia

Journal of Anesthesia

Volumn 18, Issue 3, 2004, Pages 177-180

  Moriyama, Michiru ^a   Kitamura, Akira ^a   Ikezaki, Hiroyuki ^a   Nakanishi, Kazuhiro ^a   Kim, Choru ^a   Sakamoto, Atsuhiro ^a   Ogawa, Ryo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Adenosine 5 triphosphate; Postherpetic neuralgia; Spontaneous pain; Tactile allodynia; Tactile hypesthesia

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; GLUCOSE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ALLODYNIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DRUG INFUSION; FEMALE; FLUSHING; HUMAN; HYPESTHESIA; LOW DRUG DOSE; MALE; MICTURITION DISORDER; NEUROPATHIC PAIN; OPEN STUDY; PAIN ASSESSMENT; POSTHERPETIC NEURALGIA; SINGLE BLIND PROCEDURE; SKIN MANIFESTATION; VISUAL ANALOG SCALE;

ADENOSINE TRIPHOSPHATE; AGED; FEMALE; HERPES ZOSTER; HUMANS; HYPESTHESIA; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEURALGIA; PAIN; PAIN MEASUREMENT; SINGLE-BLIND METHOD;

EID: 4644259184     PISSN: 09138668     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00540-004-0240-x     Document Type: Article

References (18)

1. Chang CM, Woo E, Yu YL, Huang CY, Chin D (1987) Herpes zoster and its neurological complications. Postgrad Med 163:85-89
2. Miller LH (1976) Herpes zoster in the elderly. Cutis 18:427-432
3. Bennett GF (1994) Neuropathic pain. In: Wall PD (ed) Textbook of pain, vol 3. Longman, London, pp 201-224
4. Agteresch HJ, Dagnelie PC, van den Berg JW, Wilson JH (1999) Adenosine triphosphate. Drugs 58:211-232
5. Todorov LD, Bjur RA, Westfall DP (1994) Inhibitory and facilitatory effects of purines on transmitter release from sympathetic nerves. J Pharmacol Exp Ther 268:985-989
6. Sawynok J, Sweeney MI (1989) The role of purines in nociceptions. Neuroscience 32:557-569
7. Burnstock G (2002) Potential therapeutic targets in the rapidly expanding field of purinergic signaling. Clin Med 2:45-53
8. Sawynok J (1997) Purines and nociception. In: Jacobson KA, Jarvis MF (ed) Purinergic approachs in experimental therapeutics. Wiley-Liss, New York, pp 495-513
9. Sollevi A, Belfrage M, Lundeberg T, Segerdahl M, Hansson P (1995) Systemic adenosine infusion: a new treatment modality to alleviate neuropathic pain. Pain 61:155-158
10. Gomma AA (1987) Characteristics of analgesia induced by adenosine triphosphate. Pharmacol Toxicol 61:199-202
11. Lynch ME, Clark AJ, Sawnok J (2003) Intravenous adenosine alleviates neuropathic pain: a double blind placebo controlled crossover trial using an enriched enrolment design. Pain 103:111-117
12. Sawynok J (2003) Topical and peripherally acting analgesics. Pharmacol Rev 55:1-20
13. Bantel C, Tobin JR, Li X, Childers SR, Chen SR, Eisenach JC (2002) Intrathecal adenosine following spinal nerve ligation in rat. Anesthesiology 96:103-108
14. Salter MW, Henry JL (1985) Effects of adenosine 5′-monophosphate and adenosine 5′-triphosphate on functionally identified units in the cat spinal dorsal horn. Evidence for a differential effect of adenosine 5′-triphosphate on nociceptive vs non-nociceptive units. Neuroscience 15:815-825
15. Belfrage M, Sollevi A, Segerdahl M, Sjolund KF, Hansson P (1995) Systemic adenosine infusion alleviates spontaneous and stimulus evoked pain in patients with peripheral neuropathic pain. Anesth Analg 81:713-717
16. Lerman BB, Belardinelli L (1991) Cardiac electrophysiology of adenosine: basic and clinical concepts. Circulation 83:1499-1509
17. Hamilton SG, Mcmahon SB (2000) ATP as a peripheral mediator of pain. J Auton Nerv Syst 81:187-194
18. Fredholm BB (1995) Purinoceptors in the nervous system. Pharmacol Toxicol 76:228-239